- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
Choose Your Country or Region
Australia
Austria
Belgium
Brazil
Canada
China
Czech Republic
Denmark
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Ireland
Israel
Italy
Japan
Korea
Luxembourg
Malaysia
Netherlands
New Zealand
Norway
Poland
Qatar
Romania
Saudi Arabia
Singapore
Spain
Sweden
Switzerland
Taiwan
Turkey
United Kingdom
United States
| Catalog No. | Product Name | Information | Selective / Pan | IC50 / Ki |
|---|---|---|---|---|
| S8012 | Otenabant (CP-945598) HCl | Otenabant (CP-945598) HCl is a potent and selective cannabinoid receptor CB1 antagonist with Ki of 0.7 nM, exhibits 10,000-fold greater selectivity against human CB2 receptor. Phase 1. | Selective | hCB1, Ki: 0.7 nM; rCB1, Ki: 2.8 nM |
| S6735 | JD-5037 | JD-5037 is a peripherally restricted (PR) cannabinoid-1 receptor blocker with an IC50 value of 2 nM for CB1 receptor and > 1000 nM for CB2 receptor. | Selective | CB1 receptor, IC50: 2 nM |
| S3021 | Rimonabant (SR141716) | Rimonabant (SR141716) is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane. Rimonabant is also a dual inhibitor of acyl CoA:cholesterol acyltransferases(ACAT) 1 and 2 and inhibits mycobacterial MmpL3. | Selective | hCB1, IC50: 13.6 nM |
| S1534 | Org 27569 | Org 27569 is an allosteric modulator of cannabinoid CB1 receptor, induces a CB1 receptor state that is characterized by enhanced agonist affinity and decreased inverse agonist affinity. | Selective | |
| S2819 | AM251 | AM251 block the inhibitory effects of endocannabinoids and synthetic cannabinoid agonists on transmitter release through an action at presynaptic cannabinoid 1 receptors in brain. | Selective | |
| S0412 | Bay 59-3074 | Bay 59-3074 is a selective cannabinoid CB1/CB2 receptor partial agonist with Ki of 55.4 nM, 48.3 nM and 45.5 nM at rat and human CB1 and human CB2 receptors, respectively. Bay 59-3074 displays analgesic properties. | Pan | rat CB1 receptor, Ki: 55.4 nM; human CB1 receptor, Ki: 48.3 nM |
| S8017 | WIN 55, 212-2 mesylate | WIN 55,212-2 Mesylate ((R)-(+)-WIN 55212) is a potent cannabinoid (CB) receptor agonist with Ki of 3.3 nM and 62.3 nM for human recombinant CB2 and CB1, respectively. WIN 55,212-2 Mesylate regulates Glutamate transmission. | Pan | CB1, Ki: 62.3 nM |
| S1544 | AM1241 | AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor. | Pan | CB1, Ki: 280 nM |
There are no products matching the selection yet, if you have any question please do not hesitate to contact us.
Selleck
Tech Support
Tel: +1-832-582-8158 Fax: +1-832-582-8590
Email: sales@selleckchem.com
Tel: +49 221 3579 1301
Email:eu.quote@selleckchem.com
Products are for research use only. Not for human use. We do not sell to patients.
©Copyright 2013 Selleck Chemicals. All Rights Reserved.